Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Bone and Mineral
- Vol. 6 (1), 77-86
- https://doi.org/10.1016/0169-6009(89)90025-1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Measurement of the subcutaneous fat in the distal forearm by single photon absorptiometryMetabolism, 1989
- CYPROTERONE ACETATE, AN ALTERNATIVE GESTAGEN IN POSTMENOPAUSAL OESTROGEN/GESTAGEN THERAPYClinical Endocrinology, 1987
- A radioimmunoassay for bone Gla protein (BGP) in human plasmaActa Endocrinologica, 1987
- Bone composition in the distal forearmScandinavian Journal of Clinical and Laboratory Investigation, 1987
- Determination of bone turnover by urinary excretion of 99mTc-MDPEuropean Journal of Nuclear Medicine and Molecular Imaging, 1986
- Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of actionMetabolism, 1983
- Changes in body composition following therapy of osteoporosis with methandrostenoloneMetabolism, 1981
- Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal femalesEuropean Journal of Clinical Investigation, 1980
- Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral massMetabolism, 1977
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976